Eyexam of California is categorized under Hospitalization Plans in Los Angeles, CA .
Eyexam of California was established in 0, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Hospitalization Plans business, which does work in the BOTH market, and is classified as a Hospitalization Plans, under code number 5241140 by the NAICS.
If you are seeking more information, feel free to contact Catherine Fleming, Site Manager at the company’s branch by writing to 8471 Beverly Boulevard # 105, Los Angeles, California CA 90048 or by phoning (310) 360-8220. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eyexam of California |
| Contact Person: | Catherine Fleming, Site Manager |
| Address: | 8471 Beverly Boulevard # 105, Los Angeles, California 90048 |
| Phone Number: | (310) 360-8220 |
| Website Address: | lenscrafters.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Hospitalization Plans |
| SIC Code: | 6324 |
| NAICS Code: | 5241140 |
| Share This Business: |
Eyexam of California was started in 0 to provide professional Hospitalization Plans under the SIC code 6324 and NAICS code 5241140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Catherine Fleming, Site Manager for inquiries that concern Eyexam of California by calling the company number (310) 360-8220, as your correspondence is most welcome. Additionally, the physical location of the branch of Eyexam of California can be found at the coordinates 34.07608,-118.37563 as well as the street address 8471 Beverly Boulevard # 105 in Los Angeles, California 90048.
For its online presence, you may visit Eyexam of California’s website at lenscrafters.com and engage with its social media outlets through on Twitter and on Facebook.